Lung transplant complications: Difference between revisions

No edit summary
No edit summary
Line 10: Line 10:


==Clinical Features/Differential Diagnosis==
==Clinical Features/Differential Diagnosis==
*Signs/symptoms of infection
*[[Fever]], [[cough]], worsening [[SOB]], hypoxia, tachypnea
==Differential Diagnosis==
===Infection===
===Infection===
*Bronchitis, [[Pneumonia]] (common)
*Bronchitis, [[Pneumonia]] (common)
Line 50: Line 46:


==Evaluation==
==Evaluation==
*CBC, BMP, tacrolimus/cyclosporine levels
*Infectious workup (including sputum and testing for opportunistic/atypical infections if indicated)
*[[CXR]], CT Chest
*Advanced/inpatient workup may include:
**Bronchoscopy
**Biopsy
**Angiography or dopplers of pulmonary vasculature


==Management==
==Management==
*See [[Immunocompromised antibiotics]], [[pneumonia]], [[sepsis]]
*See [[Pneumothorax]], [[mediastinitis]], [[pneumomediastinum]]
*Bronchoscopic debridement of necrotic, infected, or overly granulated anastomotic tissue may be needed
*Severe/symptomatic tracheobronchial stenosis may require stenting or resection


==Disposition==
==Disposition==

Revision as of 23:37, 28 September 2016

Background

  • Can transplant single lung, bilateral lungs, or heart-lungs
  • Indications: cystic fibrosis, COPD, idiopathic pulmonary fibrosis > alpha-1 antitrypsin deficiency, primary pulmonary hypertension, bronchiectasis, sarcoidosis
  • Lung is denervated
    • regulation of breathing is not lost, as it is through chest wall efferents
    • cough response lost below anastomosis
    • should have normal ABG (unless patient reliant on hypoxic respiratory drive), exercise response, and bronchomotor tone

Immunosuppressant Medications

Clinical Features/Differential Diagnosis

Infection

  • Bronchitis, Pneumonia (common)
    • usually bacterial early in course
    • MRSA and pseudomonas common
    • Fungi, protazoa, CMV more common >6 weeks post-op
  • Extra-pulmonary infections (may be severe or opportunistic due to immunosuppression)

Medication adverse effects

  • Prednisone
    • Hyperglycemia, psychiatric symptoms, poor wound healing, edema, hypertension
  • Tacrolimus, cyclosporine
    • Neurotoxicity, tremor, hyperkalemia, nephrotoxicity, hypertension, hyperglycemia, gout
  • Mycophenolate
    • Cytopenias, GI distress
  • Azathioprine
    • Cytopenias, pancreatitis, hepatitis

Airway complications

  • Anastomotic bronchial necrosis, dehiscence, or stenosis
    • bronchial vasculature is disrupted during procedure, ergo:
      • donor bronchus reliant on retrograde pulmonary circulation for perfusion
      • anastomoses vulnerable to ischemia
    • mild cases may be asymptomatic
    • may lead to worsening respiratory symptoms, pneumothorax, pneumomediastinum, focal infections/abscess
  • Occlusive granulation tissue
    • Asymptomatic, or worsening cough, wheezing, post-obstructive pneumonia
  • bronchial/tracheal stenosis, tracheobronchomalacia
    • cough, dyspnea, difficulty clearing respiratory secretions, recurrent infections, wheezing, stridor
  • bronchopleural, bronchomediastinal, or bronchovascular fisulae
  • Pulmonary vasculature problems
  • Rejection
    • Acute/cellular rejection: clinically silent or nonspecific respiratory symptoms
    • Chronic rejection (bronchiolitis obliterans): leads to airflow limitation

Evaluation

  • CBC, BMP, tacrolimus/cyclosporine levels
  • Infectious workup (including sputum and testing for opportunistic/atypical infections if indicated)
  • CXR, CT Chest
  • Advanced/inpatient workup may include:
    • Bronchoscopy
    • Biopsy
    • Angiography or dopplers of pulmonary vasculature

Management

Disposition

See Also

External Links

References